Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 577 to 626 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 577\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma-aminobutyric-acid receptor gamma-3 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q99928]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6739.81\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 7644.62\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.13425\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 578\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent forkhead box protein g1c (forkhead-related protein fkhl3) (hfk3) (fragment). [source:swissprot;acc:q14488]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 579\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma-aminobutyric-acid receptor gamma-1 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q8n1c3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6739.82\vspace{3pt}}&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 580\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma-aminobutyric-acid receptor alpha-2 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p47869]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6739.83\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 7644.63\vspace{3pt}}}&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 581\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma-aminobutyric-acid receptor alpha-6 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q16445]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6739.82\vspace{3pt}}}&&\\\cline{1-2}\cline{4-4} \parbox{\wcA}{\vspace{3pt}\noindent 582\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma-aminobutyric-acid receptor gamma-2 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p18507]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 7644.62\vspace{3pt}}}&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 583\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent interleukin-1 receptor-associated kinase 4; interleukin-1 receptor associated kinase 4. [source:refseq;acc:nm\_016123]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6739.81\vspace{3pt}}&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 584\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma-aminobutyric-acid receptor alpha-4 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p48169]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6739.82\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 7644.63\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 585\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma-aminobutyric-acid receptor epsilon subunit precursor (gaba(a) receptor). [source:swissprot;acc:p78334]\vspace{3pt}}&&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 586\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent phosphatidylserine receptor; phosphatidylserine receptor beta. [source:refseq;acc:nm\_015167]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6739.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7644.62\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 587\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma-aminobutyric-acid receptor alpha-1 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p14867]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6739.83\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 7644.63\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 588\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma-aminobutyric-acid receptor alpha-3 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p34903]\vspace{3pt}}&&&\\\cline{1-3}\cline{5-5} \parbox{\wcA}{\vspace{3pt}\noindent 589\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nadh-ubiquinone oxidoreductase b14 subunit (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b14) (ci-b14). [source:swissprot;acc:p56556]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6739.85\vspace{3pt}}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.13424\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 590\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent similar to expressed sequence aa415817. [source:sptrembl;acc:q8n4q9]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 591\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent homeobox protein hox-d9 (hox-4c) (hox-5.2). [source:swissprot;acc:p28356]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6740.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7644.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.13415\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 592\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent histone h2b.c (h2b/c). [source:swissprot;acc:q99880]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 3946.32\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 4475.47\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.13409\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 593\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent histone h2b.q (h2b/q) (h2b-gl105). [source:swissprot;acc:q16778]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 594\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent histone h3.1 (h3/a) (h3/c) (h3/d) (h3/f) (h3/h) (h3/i) (h3/j) (h3/k) (h3/l). [source:swissprot;acc:p16106]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 595\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent histone h2b. [source:refseq;acc:nm\_175055]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 596\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent histone h2b.s (h2b/s). [source:swissprot;acc:p57053]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 597\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent histone h2b.d (h2b/d). [source:swissprot;acc:q99877]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 598\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent histone h3.4 (h3t) (h3/t) (h3/g). [source:swissprot;acc:q16695]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 599\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent testis-specific histone h2b; h2b histone family, member u, (testis-specific). [source:refseq;acc:nm\_170610]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 600\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent histone h2b.e (h2b/e). [source:swissprot;acc:q99879]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 601\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent symplekin. [source:swissprot;acc:q92797]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 15213.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 13418.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.1338\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 602\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ataxin 2 related protein isoform a; ataxin-2 domain protein. [source:refseq;acc:nm\_007245]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 4864.66\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5514.87\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.13366\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 603\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ataxin 2; olivopontocerebellar ataxia 2, autosomal dominant. [source:refseq;acc:nm\_002973]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 604\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent vinculin (metavinculin). [source:swissprot;acc:p18206]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5958.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6743.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.13177\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 605\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent probable calcium-transporting atpase kiaa0703 (ec 3.6.3.8). [source:swissprot;acc:o75185]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6143.52\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6950.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.1314\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 606\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent calcium-transporting atpase type 2c, member 1 (ec 3.6.3.8) (atpase 2c1) (atp-dependent ca(2+) pump pmr1) (hussy-28). [source:swissprot;acc:p98194]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6148.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6955.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.13121\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 607\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent likely ortholog of mouse variant polyadenylation protein cstf-64. [source:refseq;acc:nm\_015235]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 14976.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 13246.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.13058\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 608\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nuclear transcription factor y subunit beta (nf-y protein chain b) (nf-yb) (ccaat-binding transcription factor subunit a) (cbf-a) (caat- box dna binding protein subunit b). [source:swissprot;acc:p25208]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4510.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5098.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.13039\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 609\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent b9 protein; likely ortholog of mouse endothelial precursor protein b9. [source:refseq;acc:nm\_015681]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3886.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3438.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.13022\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 610\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent kynureninase (ec 3.7.1.3) (l-kynurenine hydrolase). [source:swissprot;acc:q16719]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 8430.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 9518.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12907\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 611\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dynein intermediate chain 2, cytosolic (dh ic-2) (cytoplasmic dynein intermediate chain 2). [source:swissprot;acc:q13409]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5148.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5811.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12878\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 612\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 3 subunit 2 (eif-3 beta) (eif3 p36) (eif3i) (tgf-beta receptor interacting protein 1) (trip-1). [source:swissprot;acc:q13347]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 3975.77\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 4485.05\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.1281\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 613\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent trinucleotide repeat containing 15. [source:refseq;acc:nm\_015575]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 614\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent solute carrier family 4 (anion exchanger), member 1, adaptor protein; kidney anion exchanger adaptor protein; kanadaptin; lung cancer oncogene 3. [source:refseq;acc:nm\_018158]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 11222.2\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 9948.93\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.12798\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 615\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cyclin-dependent kinases regulatory subunit 2 (cks-2). [source:swissprot;acc:p33552]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 616\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent catenin (cadherin-associated protein), alpha-like 1; alpha-catulin. [source:refseq;acc:nm\_003798]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 617\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dynein intermediate chain 1, cytosolic (dh ic-1) (cytoplasmic dynein intermediate chain 1). [source:swissprot;acc:o14576]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5162.52\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5822.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12783\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 618\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nucleoside diphosphate kinase 3 (ec 2.7.4.6) (ndk 3) (ndp kinase 3) (nm23-h3) (dr-nm23). [source:swissprot;acc:q13232]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7878.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8879.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12703\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 619\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nucleolar protein nop56 (nucleolar protein 5a). [source:swissprot;acc:o00567]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3879.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4371.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12661\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 620\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ferritin heavy chain (ferritin h subunit). [source:swissprot;acc:p02794]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6227.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7012.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12605\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 621\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ftsj homolog 3; likely ortholog of mouse ectoplacental cone, invasive trophoblast giant cells, extraembryonic ectoderm and chorion sequence 3. [source:refseq;acc:nm\_017647]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4115.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4633.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12601\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 622\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitochondrial ferritin; ferritin heavy chain-like; ferritin h subunit. [source:refseq;acc:nm\_177478]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6228.42\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7013.21\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.126\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 623\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cellular repressor of e1a-stimulated genes 2. [source:refseq;acc:nm\_153836]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6228.39\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 7013.19\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 624\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dj681n20.2 (novel protein similar to ferritin, light polypeptide (ftl)). [source:sptrembl;acc:q9byw6]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 625\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent disks large-associated protein 1 (dap-1) (guanylate kinase-associated protein) (hgkap) (sap90/psd-95-associated protein 1) (sapap1) (psd- 95/sap90 binding protein 1). [source:swissprot;acc:o14490]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 626\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent putative adenosylhomocysteinase 2 (ec 3.3.1.1) (s-adenosyl-l- homocysteine hydrolase) (adohcyase). [source:swissprot;acc:o43865]\vspace{3pt}}&&&\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/